212 related articles for article (PubMed ID: 7994815)
1. Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy.
Fananapazir L; Epstein ND; Curiel RV; Panza JA; Tripodi D; McAreavey D
Circulation; 1994 Dec; 90(6):2731-42. PubMed ID: 7994815
[TBL] [Abstract][Full Text] [Related]
2. Transcatheter Myotomy to Reduce Left Ventricular Outflow Obstruction.
Greenbaum AB; Ueyama HA; Gleason PT; Khan JM; Bruce CG; Halaby RN; Rogers T; Hanzel GS; Xie JX; Byku I; Guyton RA; Grubb KJ; Lisko JC; Shekiladze N; Inci EK; Grier EA; Paone G; McCabe JM; Lederman RJ; Babaliaros VC
J Am Coll Cardiol; 2024 Apr; 83(14):1257-1272. PubMed ID: 38471643
[TBL] [Abstract][Full Text] [Related]
3. Distinguishing left ventricular hypertrophy from hypertrophic cardiomyopathy in adolescents: a longitudinal observation study.
Forså MI; Smedsrud MK; Haugaa KH; Bjerring AW; Früh A; Sarvari SI; Landgraff HW; Hallén J; Edvardsen T
Eur J Prev Cardiol; 2024 Mar; 31(5):591-598. PubMed ID: 37992187
[TBL] [Abstract][Full Text] [Related]
4. Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy.
Maron MS; Masri A; Nassif ME; Barriales-Villa R; Arad M; Cardim N; Choudhury L; Claggett B; Coats CJ; Düngen HD; Garcia-Pavia P; Hagège AA; Januzzi JL; Lee MMY; Lewis GD; Ma CS; Michels M; Olivotto I; Oreziak A; Owens AT; Spertus JA; Solomon SD; Tfelt-Hansen J; van Sinttruije M; Veselka J; Watkins H; Jacoby DL; Heitner SB; Kupfer S; Malik FI; Meng L; Wohltman A; Abraham TP;
N Engl J Med; 2024 May; 390(20):1849-1861. PubMed ID: 38739079
[TBL] [Abstract][Full Text] [Related]
5. Effect of Mavacamten on Chinese Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy: The EXPLORER-CN Randomized Clinical Trial.
Tian Z; Li L; Li X; Wang J; Zhang Q; Li Z; Peng D; Yang P; Ma W; Wang F; Jin W; Cheng X; Sun J; Fu Y; Lyu C; Zhang S
JAMA Cardiol; 2023 Oct; 8(10):957-965. PubMed ID: 37639259
[TBL] [Abstract][Full Text] [Related]
6. Mavacamten for Obstructive Hypertrophic Cardiomyopathy With or Without Hypertension: Post-Hoc Analysis of the EXPLORER-HCM Trial.
Wang A; Spertus JA; Wojdyla DM; Abraham TP; Nilles EK; Owens AT; Saberi S; Cresci S; Sehnert A; Lakdawala NK
JACC Heart Fail; 2024 Mar; 12(3):567-579. PubMed ID: 37855754
[TBL] [Abstract][Full Text] [Related]
7. Obstruction in Hypertrophic Cardiomyopathy: Many Faces.
Abbasi M; Ong KC; Newman DB; Dearani JA; Schaff HV; Geske JB
J Am Soc Echocardiogr; 2024 Jun; 37(6):613-625. PubMed ID: 38428652
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and Safety of Mavacamten in the Treatment of Hypertrophic Cardiomyopathy: A Systematic Review.
Bishev D; Fabara S; Loseke I; Alok A; Al-Ani H; Bazikian Y
Heart Lung Circ; 2023 Sep; 32(9):1049-1056. PubMed ID: 37453852
[TBL] [Abstract][Full Text] [Related]
9. Three-dimensional haemodynamics in patients with obstructive and non-obstructive hypertrophic cardiomyopathy assessed by cardiac magnetic resonance.
Allen BD; Choudhury L; Barker AJ; van Ooij P; Collins JD; Bonow RO; Carr JC; Markl M
Eur Heart J Cardiovasc Imaging; 2015 Jan; 16(1):29-36. PubMed ID: 25108915
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous intramyocardial septal radiofrequency ablation after 5-year follow-up.
Ta S; Li J; Hsi DH; Hu R; Lei C; Shan B; Li W; Wang J; Wang B; Kang N; Li X; Liu J; Qi C; Huang J; Han Y; Ruan F; Zhang J; Liu L
Heart; 2024 May; 110(11):792-799. PubMed ID: 38388470
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Safety and Efficacy of Mavacamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy: Interim Results of the PIONEER-OLE Study.
Masri A; Lester SJ; Stendahl JC; Hegde SM; Sehnert AJ; Balaratnam G; Shah A; Fox S; Wang A
J Am Heart Assoc; 2024 Apr; 13(8):e030607. PubMed ID: 38591260
[TBL] [Abstract][Full Text] [Related]
12. Radiofrequency ablation in patients with obstructive hypertrophic cardiomyopathy: A systematic review and meta-analysis.
Canzi CC; do Prado Júnior ER; da Silva Menezes Júnior A; Rezende AL; Botelho SM; Santos LDR
Am Heart J Plus; 2022 Dec; 24():100229. PubMed ID: 38560638
[TBL] [Abstract][Full Text] [Related]
13. Left ventricular anatomy in obstructive hypertrophic cardiomyopathy: beyond basal septal hypertrophy.
Hermida U; Stojanovski D; Raman B; Ariga R; Young AA; Carapella V; Carr-White G; Lukaschuk E; Piechnik SK; Kramer CM; Desai MY; Weintraub WS; Neubauer S; Watkins H; Lamata P
Eur Heart J Cardiovasc Imaging; 2023 May; 24(6):807-818. PubMed ID: 36441173
[TBL] [Abstract][Full Text] [Related]
14. Energy loss by right ventricular pacing: Patients with versus without hypertrophic cardiomyopathy.
Arakawa Y; Fukaya H; Kakizaki R; Oikawa J; Saito D; Sato T; Matsuura G; Kobayashi S; Shirakawa Y; Nishinarita R; Horiguchi A; Ishizue N; Nabeta T; Kishihara J; Niwano S; Ako J
J Arrhythm; 2021 Feb; 37(1):203-211. PubMed ID: 33664904
[TBL] [Abstract][Full Text] [Related]
15. Sitting maneuver to uncover latent left ventricular outflow tract obstruction in patients without hypertrophic cardiomyopathy.
Sekine A; Watanabe T; Nakabo A; Ichiryu H; Endo S; Hayashi M; Naruse G; Nakayama J; Takada A; Fujimoto S; Ozawa N; Inada T; Nohisa Y; Kikuchi R; Kanamori H; Okura H
J Cardiol; 2024 Jun; 83(6):401-406. PubMed ID: 38000537
[TBL] [Abstract][Full Text] [Related]
16. Dramatic improvement of refractory anemia caused by mechanical hemolysis in a patient with hypertrophic obstructive cardiomyopathy using dual-chamber pacing.
Miwa Y; Soejima K; Sato T; Matsushita K; Sueoka J; Takayama N; Yoshino H
J Arrhythm; 2015 Aug; 31(4):243-5. PubMed ID: 26336568
[TBL] [Abstract][Full Text] [Related]
17. Late Outcomes of Konno-Rastan and Modified Konno for Left Ventricular Outflow Tract Obstruction.
Griffeth EM; Dearani JA; Hassler KR; Todd A; Johnson JN; Miranda WR; Stephens EH
Ann Thorac Surg; 2024 May; 117(5):973-981. PubMed ID: 37479125
[TBL] [Abstract][Full Text] [Related]
18. The Efficacy of Cardiac Myosin Inhibitors Versus Placebo in Patients With Symptomatic Hypertrophic Cardiomyopathy: A Meta-Analysis and Systematic Review.
Yassen M; Changal K; Busken J; Royfman R; Schodowski E; Venkataramany B; Khouri SJ; Moukarbel GV
Am J Cardiol; 2024 Jan; 210():219-224. PubMed ID: 37884110
[TBL] [Abstract][Full Text] [Related]
19. Outflow tract ventricular premature beats ablation in the presence or absence of structural heart disease: Technical considerations and clinical outcomes.
Badran H; Samir R; Amin M
Egypt Heart J; 2017 Dec; 69(4):273-280. PubMed ID: 29622988
[TBL] [Abstract][Full Text] [Related]
20. Mid-Term Outcomes: a Comprehensive Approach to Surgery for Hypertrophic Obstructive Cardiomyopathy.
Wong LY; Vila R; Lantz G; Doberne J; Bhamidipati CM; Tibayan FA; Masri A; Song HK
Ann Thorac Surg; 2024 Jun; ():. PubMed ID: 38851415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
